Editorial commentary
ChiCTR, the Chinese Clinical Trial Registry, is China’s national public clinical trial registry. It was established in 2005 by Professor Wu Taixiang and colleagues at the Chinese Cochrane Centre / Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University, which continues to manage and fund the registry. In 2007, China’s Ministry of Health (predecessor to today’s National Health Commission) designated ChiCTR as the country’s representative registry, and it was accepted as the fourth Primary Registry in the WHO International Clinical Trials Registry Platform (ICTRP) network.
Last verified August 25, 2026 against WHO’s ICTRP registry profile for ChiCTR and ChiCTR’s own about page.
What is the Chinese Clinical Trial Registry (ChiCTR)?
The Chinese Clinical Trial Registry (ChiCTR) is China’s national public registry for clinical trials, hosted at chictr.org.cn in Simplified Chinese and English. It is a non-profit, WHO ICTRP Primary Registry, so a trial registered there meets the registration expectation of ICMJE-member journals. Registration is free of charge.
WHO ICTRP Primary Registry Status
As a WHO ICTRP Primary Registry, ChiCTR’s registration procedures and required data fields comply with ICTRP and ICMJE standards, meaning a trial registered there satisfies the Declaration of Helsinki’s registration expectation and the trial-registration precondition ICMJE-member journals apply before considering a manuscript for publication — the same standing held by ClinicalTrials.gov, ISRCTN, and CTRI. ChiCTR publishes the full WHO Trial Registration Data Set for each study: primary and secondary outcomes, recruitment status, target sample size, and inclusion/exclusion criteria among them.
Scope and Who Can Register
ChiCTR accepts prospective registration of interventional trials from investigators in any country, not only China — unusually broad among national registries, most of which register only trials sponsored or conducted domestically. It also accepts a wider range of study types than some peer registries, including non-randomized and observational designs alongside standard randomized controlled trials.
Registration Number Format
ChiCTR’s registration-number format has changed over time. Its current format, used since roughly 2019, is ChiCTR followed by a two-digit year and a sequential number — for example, ChiCTR2200054321 or the earlier ChiCTR1900027785. WHO’s own registry-profile documentation also describes an older, still-referenced scheme that embedded a trial-type code in the identifier (for example, ChiCTR-TRC-xxxxxxxx, where TRC denoted a therapeutic randomized controlled trial, DT a diagnostic-test study, and PRC a prevention RCT); researchers encountering an older ChiCTR identifier in the published literature may see either format depending on the study’s original registration date.
How to Register a Trial and Search ChiCTR
According to ChiCTR’s own about page, the process runs as follows:
- Create a personal account on the ChiCTR website, log in, and open “Project info” then “Project management”.
- Select “New” and complete the online registration form. Registrants upload an ethics approval letter and a study protocol with informed consent; the protocol must follow GCP and SPIRIT standards or the application is rejected.
- ChiCTR reviewers check the project against the registration criteria and may contact the registrant by phone or email for clarification. Saved edits are kept as historical versions.
- Once the project is eligible, a registration number is issued. Within four weeks, the registrant should apply for a Universal Trial Number (UTN) from WHO ICTRP and enter it in the “Secondary ID” field.
- Results data should be uploaded within one year of trial completion, after which it is made public.
ChiCTR states that registration is free of charge. To look up existing studies, use the “Trial Search” page on the same site; the registry lists complete registrations split into prospective and retrospective, and into interventional and observational study types. Trials registered in ChiCTR are also discoverable through the WHO ICTRP search portal. Other national primary registries follow similar models, for example ANZCTR in Australia and New Zealand and TCTR in Thailand.
A Notable Limit: No Statutory Reporting Backing
ChiCTR’s terms of use require summary results to be uploaded within one year of trial completion, but — per WHO’s own registry-profile assessment — this requirement is not currently backed by Chinese national law, unlike, for example, the results-reporting mandate ClinicalTrials.gov carries under FDAAA 801 for applicable US trials. Registration itself functions in practice mainly as a precondition for publication in ICMJE-compliant journals and as an ethical-transparency norm reinforced by China’s own research-integrity guidance, rather than as an independently enforced statutory obligation.
ChiCTR vs. Other Primary Registries
| ChiCTR | CTRI (India) | ClinicalTrials.gov | |
|---|---|---|---|
| Operator | West China Hospital, Sichuan University | Indian Council of Medical Research | US National Library of Medicine (NIH) |
| WHO ICTRP status | Primary Registry (since 2007) | Primary Registry | Primary Registry |
| Statutory reporting mandate? | Not currently, per WHO’s assessment | Registration mandatory under the New Drugs and Clinical Trials Rules, 2019 | Yes — FDAAA 801, 42 CFR Part 11, for applicable trials |
| Accepts non-domestic registrants? | Yes, explicitly | Primarily India-focused | Yes, for FDA-regulated trials regardless of location |
Why This Matters for Research Administration
For research administrators coordinating multi-country trials that include China-based sites, ChiCTR registration is typically pursued to satisfy the target journal’s ICMJE-style registration requirement and China’s own research-ethics expectations, rather than a hard statutory reporting deadline of the kind FDAAA 801 imposes in the US — that distinction affects how much regulatory urgency to build into a China-site trial’s registration timeline relative to a US-regulated one, even though both should still be registered prospectively as good practice.
Frequently Asked Questions
Is ChiCTR only for trials conducted in China?
No. ChiCTR explicitly accepts prospective interventional trial registrations from investigators in any country, though it is most commonly used for China-based studies.
Is ChiCTR a WHO-recognized registry?
Yes. It has been a WHO ICTRP Primary Registry since 2007, the fourth registry admitted to that network.
Does China legally require trial registration in ChiCTR?
Registration and results-reporting are required by ChiCTR’s own terms of use and are expected under China’s research-ethics norms and ICMJE publication requirements, but per WHO’s registry-profile assessment, the results-reporting requirement specifically is not currently backed by Chinese national law in the way FDAAA 801 backs ClinicalTrials.gov reporting in the US.
What does a ChiCTR registration number look like?
The current format is ChiCTR followed by a two-digit year and a sequential number, for example ChiCTR2200054321.
References
- WHO ICTRP, “Chinese Clinical Trial Registry (ChiCTR)” primary-registry profile.
- Wu T. et al., “Chinese Clinical Trial Registry: mission, responsibility and operation,” Journal of Evidence-Based Medicine, 2011.
- Chinese Clinical Trial Registry, official site (chictr.org.cn): about page.
Examples
Worked examples
- Is an instance
A China-based investigator registers a randomized controlled trial in ChiCTR before enrollment, receiving an identifier such as ChiCTR2200054321.
- Is an instance
A systematic reviewer searches ChiCTR directly, or via WHO's ICTRP portal, to find China-based trials on a given intervention that may not appear in ClinicalTrials.gov.
Counter-examples
Looks similar, but isn't
- Not an instance
Assuming ChiCTR registration is backed by a Chinese statutory reporting mandate equivalent to FDAAA 801 in the US -- as of ChiCTR's own published policies, its results-reporting terms of use are not backed by national law, unlike some other primary registries.
- Not an instance
Treating ChiCTR as accepting only China-based trials -- it explicitly accepts prospective interventional trial registrations from investigators in any country.
Also known as
Chinese Clinical Trial Registry · ChiCTR registration number
Machine-readable encodings
Use in your systems
<kwd vocab="CASRAI Dictionary"
vocab-identifier="https://casrai.org/dictionary/"
vocab-term="ChiCTR (Chinese Clinical Trial Registry)"
vocab-term-identifier="https://casrai.org/dictionary/term/chictr-chinese-clinical-trial-registry">ChiCTR (Chinese Clinical Trial Registry)</kwd>Schema.org DefinedTerm (JSON-LD)
{
"@context": "https://schema.org",
"@type": "DefinedTerm",
"@id": "https://casrai.org/dictionary/term/chictr-chinese-clinical-trial-registry",
"name": "ChiCTR (Chinese Clinical Trial Registry)",
"identifier": "https://casrai.org/dictionary/term/chictr-chinese-clinical-trial-registry",
"description": "The Chinese Clinical Trial Registry (ChiCTR) is China's national clinical trial registry, established in 2005 by the Chinese Cochrane Centre/Chinese Evidence-Based Medicine Centre team at West China Hospital, Sichuan University, and accepted in 2007 as the fourth WHO International Clinical Trials Registry Platform (ICTRP) Primary Registry, with the Ministry of Health of China (now the National Health Commission) designating it as China's official representative to that network. ChiCTR accepts registration of both interventional and observational studies, from China and internationally, and publishes the full WHO Trial Registration Data Set for each registered study.",
"inDefinedTermSet": "https://casrai.org/dictionary/domain/clinical-research#set",
"url": "https://casrai.org/dictionary/term/chictr-chinese-clinical-trial-registry",
"alternateName": [
"Chinese Clinical Trial Registry",
"ChiCTR registration number"
],
"license": "https://creativecommons.org/licenses/by/4.0/",
"publisher": {
"@id": "https://casrai.org/#organization"
},
"author": {
"@id": "https://casrai.org/#editorial-team"
},
"datePublished": "2026-08-25T05:40:25Z",
"dateModified": "2026-11-13T21:51:29Z",
"inLanguage": "en",
"isAccessibleForFree": true
}






